Item 5. Market for Registrant’s Common Equity
Item 5. Market for Registrant’s Common Equity, Related
Stockholder Matters and Issuer Purchases of Equity Securities.
Market Information
Our common stock is currently quoted on the
OTC Pink tier of the over-the-counter market maintained by OTC Markets Group, Inc. under the symbol “ SSII. ”
However, the trading market for our common stock is sporadic and extremely limited. Moreover, until the review of the Form 15c2-11
which has been filed with FINRA on our behalf is cleared by FINRA (as to which no assurance can be given), our common stock is not
eligible for proprietary broker-dealer quotations on the over-the-counter market and may only be bought or sold in unsolicited
customer orders. This further limits the trading market for our common stock. The Company has also applied to list its common stock
on the Nasdaq Stock Market, LLC, although there is no assurance that such application will be approved or that in either case, a
liquid trading market for the common stock will develop and be sustained.
Holders of our Common Stock
As of the date of this Annual Report, we had 193,559,340
shares of common stock issued and outstanding and 343 holders of record of our common stock. One of these holders is CEDE and Company,
which is the mechanism used for brokerage firms to hold securities in book entry form on behalf of their clients and as of the date of
this Annual Report, they held approximately 15,051,246 shares of common stock for these shareholders.
Dividends
The payment by us of dividends, if any, in the
future rests within the discretion of our board of directors and will depend, among other things, upon our earnings, capital requirements
and financial condition, as well as other relevant factors. We have not paid any dividends since our inception and we do not intend to
pay any cash dividends in the foreseeable future, but intend to retain all earnings, if any, for use in our business.
Securities Authorized for Issuance under Equity
Compensation Plans
Plan category
Number of
securities to
be issued upon
exercise
of outstanding
options, grants
warrants and
rights
Weighted-
average
exercise
price of
outstanding
options,
grants
warrants and
rights
Number of
securities
remaining
available for future
issuance
under equity
compensation
plans (excluding
securities
reflected in
column
(a))
Equity compensation plans approved by security holders
12,142,838 shares
(1)
$
3.863
7,213,096 shares
(1)
Equity compensation plans not approved by security holders
0 shares
–
0 shares
Total
12,142,838
(1)
$ 0
7,213,096
(1)
(1) Represents
shares of common stock under our 2016 Incentive Stock Plan (the “ Incentive Plan ”). As of the date of this Annual Report,
12,142,838 shares of common stock (comprised of 7,767,431 stock options and 4,375,407 stock grants) were issued under the Incentive Stock
Plan. As of the date of this Annual Report, an additional 7,213,096 shares of common stock are available for future issuances under the
Incentive Stock Plan.
24
Recent Sales of Unregistered Securities
In March 2024, the Company issued 15,000 shares
of common stock to an investor relations firm for investor relations and digital marketing services.
In August 2024, the Company issued 125,000 shares
to certain doctors/proctors for providing their proctoring/mentoring services.
In December 2024, the Company issued 9,034 shares
of common stock to a marketing advisory services firm for providing dedicated support, production, graphics, post-production and distribution
services.
All of the foregoing securities were
issued in accordance with the exemption from registration afforded by Section 4(a)(2) of and/or Regulation D under the Securities Act,
as amended, as the persons receiving such shares having provided the Company with appropriate representations as to their investment intent
and their status as “ accredited investors ” as defined in Rule 501(a) of Regulation D promulgated under the Securities
Act.
Item 6. [Reserved]